Co-Diagnostics signs MoU with partner in Kingdom of Saudi Arabia

Co-Diagnostics (CODX) announced that it has signed a strategic Memorandum of Understanding with a regional manufacturing and distribution company located in the Kingdom of Saudi Arabia, to explore a joint venture that would be granted a license to develop, manufacture, and sell Co-Dx intellectual property throughout the Middle East and North Africa, including the company’s upcoming Co-Dx PCR point-of-care platform. According to the MOU, the KSA partner company in the JV would contribute local operational s ...